Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Cognition - Other clinical trials

A small indexed set (5 trials) with no open enrollment listed right now.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count

Cognition - Other: 5 US clinical trials tracked, none currently recruiting.

Cognition - Other is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is University of Illinois at Urbana-Champaign, running 2 of these trials.

Enrollment posture brief

Registry condition cognition-other

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cognition - Other (this)0%
Open-enrollment share among volume-matched conditions near Cognition - Other

Cognition - Other has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cognition - Other on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cognition - Other is recruiting below its size-band peers.

    0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cognition - Other research.

    University of Illinois at Urbana-Champaign accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Cognition - Other trials plan to enrol fewer than 100 people.

    Median target enrolment is 66 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Cognition - Other research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Cognition - Other records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Yogurt with B. lactis and added cane sugar Dietary supplement
1 trials
Yogurt with heat-inactivated B. lactis and added cane sugar Dietary supplement
1 trials
Yogurt with B. lactis and added honey Dietary supplement
1 trials
Internet Navigational Other
1 trials
Black rice extract Dietary supplement
1 trials
Speed of Processing Training Behavioral
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Cognition - Other trials. A trial with sites in several states counts in each.

Illinois 2 trials
New York 1 trials
California 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cognition - Other page

5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cognition - Other condition card totals 5 registered trials; most-linked intervention Yogurt with B. lactis and added cane sugar; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.